These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10432478)

  • 1. Increased levels of proneurotensin/neuromedin N mRNA in rat striatum and nucleus accumbens induced by 7-OH-DPAT and nafadotride.
    Levant B; Garimelli B; Shafer RA; Merchant KM
    Neuropsychopharmacology; 1999 Aug; 21(2):304-11. PubMed ID: 10432478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurochemical evidence that postsynaptic nucleus accumbens D3 receptor stimulation enhances cocaine reinforcement.
    Parsons LH; Caine SB; Sokoloff P; Schwartz JC; Koob GF; Weiss F
    J Neurochem; 1996 Sep; 67(3):1078-89. PubMed ID: 8752115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated imipramine treatment enhances the 7-OH-DPAT-induced hyperactivity in rats: the role of dopamine D2 and D3 receptors.
    Rogóz Z; Skuza G
    Pol J Pharmacol; 2001; 53(6):571-6. PubMed ID: 11985330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in local cerebral glucose utilization produced by D3 dopamine receptor-selective doses of 7-OH-DPAT and nafadotride.
    Levant B; Cross RS; Pazdernik TL
    Brain Res; 1998 Nov; 812(1-2):193-9. PubMed ID: 9813322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine D3 modulation of locomotor activity and sleep in the nucleus accumbens and in lobules 9 and 10 of the cerebellum in the rat.
    Barik S; de Beaurepaire R
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):718-26. PubMed ID: 15913875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D3 receptor modulation of dopamine efflux in the rat nucleus accumbens.
    Roberts C; Cummins R; Gnoffo Z; Kew JN
    Eur J Pharmacol; 2006 Mar; 534(1-3):108-14. PubMed ID: 16490190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
    Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anticataleptic effect of 7-OH-DPAT: are dopamine D3 receptors involved?
    Maj J; Rogóz Z; Skuza G
    J Neural Transm (Vienna); 1999; 106(11-12):1063-73. PubMed ID: 10651103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of muscimol on haloperidol-induced alteration of neurotensin gene expression in the striatum and nucleus accumbens in the rat.
    Decker KP; Roy-Byrne PP; Merchant KM
    Brain Res; 1995 Sep; 691(1-2):9-17. PubMed ID: 8590069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-fos antisense oligonucleotide specifically attenuates haloperidol-induced increases in neurotensin/neuromedin N mRNA expression in rat dorsal striatum.
    Merchant KM
    Mol Cell Neurosci; 1994 Aug; 5(4):336-44. PubMed ID: 7804603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D2 and D3 receptors in the rat striatum and nucleus accumbens: use of 7-OH-DPAT and [125I]-iodosulpride.
    Booze RM; Wallace DR
    Synapse; 1995 Jan; 19(1):1-13. PubMed ID: 7709338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo evidence for preferential role of dopamine D3 receptor in the presynaptic regulation of dopamine release but not synthesis.
    Gainetdinov RR; Sotnikova TD; Grekhova TV; Rayevsky KS
    Eur J Pharmacol; 1996 Jul; 308(3):261-9. PubMed ID: 8858296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; jaw movements.
    Koshikawa N; Miwa Y; Adachi K; Kobayashi M; Cools AR
    Eur J Pharmacol; 1996 Jul; 308(3):227-34. PubMed ID: 8858292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents.
    Sautel F; Griffon N; Sokoloff P; Schwartz JC; Launay C; Simon P; Costentin J; Schoenfelder A; Garrido F; Mann A
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1239-46. PubMed ID: 8531087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BMY 14802, a potential antipsychotic drug, increases expression of proneurotensin mRNA in the rat striatum.
    Levant B; Merchant KM; Dorsa DM; Nemeroff CB
    Brain Res Mol Brain Res; 1992 Feb; 12(4):279-84. PubMed ID: 1349718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study).
    Sotnikova TD; Gainetdinov RR; Grekhova TV; Rayevsky KS
    Pharmacol Res; 2001 Mar; 43(3):283-90. PubMed ID: 11401421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biphasic inhibition of stimulated endogenous dopamine release by 7-OH-DPAT in slices of rat nucleus accumbens.
    Patel J; Trout SJ; Palij P; Whelpton R; Kruk ZL
    Br J Pharmacol; 1995 Jun; 115(3):421-6. PubMed ID: 7582452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mu opioid receptor mRNA in nucleus accumbens is elevated following dopamine receptor activation.
    Azaryan AV; Clock BJ; Cox BM
    Neurochem Res; 1996 Nov; 21(11):1411-5. PubMed ID: 8947931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194.
    Audinot V; Newman-Tancredi A; Gobert A; Rivet JM; Brocco M; Lejeune F; Gluck L; Desposte I; Bervoets K; Dekeyne A; Millan MJ
    J Pharmacol Exp Ther; 1998 Oct; 287(1):187-97. PubMed ID: 9765337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental differences in dopamine synthesis inhibition by (+/-)-7-OH-DPAT.
    Andersen SL; Dumont NL; Teicher MH
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Aug; 356(2):173-81. PubMed ID: 9272722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.